S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
66,000% upside on tiny biotech? (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
All the trading advice you’ve ever received boils down to this (Ad)
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
AT&T will give $5 to customers hit by cellphone network outage

After blowout earnings, Integer may be headed to new highs

 Integer Holdings stock price

Key Points

  • Integer recently announced stunning Q3 results, including 34% EPS growth that marked the company’s best profit jump in nearly two years.
  • With a focus on product and service expansions, Integer appears headed down a path of higher growth and profitability.
  • Based on management’s revised EPS guidance, the stock is trading at 19x this year’s earnings estimate - which puts it in deep discount territory compared to its peer group.
  • 5 stocks we like better than Integer

An integer can be any number, positive or negative — but for Integer Holdings Corporation NYSE: ITGR, the number 105 may be a good fit.

On October 27th, Benchmark Co. analyst Robert Wasserman gave the medical device outsource (MDO) manufacturer a Buy rating and $105 price target. The target forecasts that the mid-cap 1) has more than 20% upside from last week’s close and 2) will surpass its July 2021 record high of $101.61 within the next 12 months.

The research firm’s bullish view follows blowout third quarter results from the Texas-based company. Integer recently announced that Q3 revenue increased 18% year-over-year to $405 million, led by strong performances in its two largest segments — Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation. The 20% sales growth recorded in both businesses reflects strong end-market demand for electrophysiology, structural heart and pre-market approval (PMA) products.

Even more impressive than the top line growth was 34% earnings per share (EPS) growth which marked the company’s best profit jump in nearly two years. With Wall Street anticipating approximately 16% EPS growth, the convincing beat was aided by margin expansion tied to a supply chain recovery and successful cost containment. 

Management backed up the Q3 results by raising its full-year guidance. Expecting market share gains, it raised revenue growth guidance to 14% to 16% (from 11% to 13%) and adjusted EPS to $4.47 to $4.67 (from $4.23 to $4.43). The revised 2023 EPS outlook points to 18% growth at the midpoint after the company posted a 5% profit decline in 2022. 

Integer shares gapped up more than 15% on the news and have added to the gains amid a broad rally in U.S. equities. A growth strategy that includes both in-house expansion and acquisition activity could keep the run going well into 2024.


What are Integer’s growth drivers?

Integer’s core business is to make medical devices for original equipment manufacturers (OEMs) that span the entire health care sector. Drug delivery systems, implants, catheters, pulse generators and surgical tools are a small sample of its capabilities. If you’ve ever had a medical procedure that involves these or related products, there’s a good chance it was made by Integer.

In recent months, however, the company has expanded its customer offerings to include development-stage services and clinical support. This has allowed it to play a bigger role in the medical device product lifecycle and generate higher revenue

At the same time, Integer is devoting attention to faster-growing, more profitable markets like electrophysiology, heart structure and neurovascular. Early-stage PMA projects in particular, have become a key part of the business. Such projects account for 80% of Integer’s product pipeline, which shows that the market for innovative medical devices in the post-pandemic healthcare world is red hot.

In addition to broadening its in-house capabilities, Integer is looking outside of its own walls for growth opportunities. Last month, the company paid $42 million to acquire neurovascular catheter maker InNeuro, which has higher profit margins than Integer. The takeover is Integer’s third in as many years after it acquired low-cost manufacturer Oscor in late 2021 and biomaterial technologies provider Aran Biomedical last year. Management noted that both of these businesses are exceeding internal expectations.

Given the product and service expansions, Integer appears to be headed down a path of higher growth and profitability. Even after the recent rally though, its stock may be too cheap.

Is Integer Holdings stock undervalued?

From 2020 to 2022, Integer traded within a wide P/E band of 20x to 45x, which was largely related to market volatility. Based on management’s revised EPS guidance, the stock is trading at 19x this year’s earnings estimate (at the midpoint). This shows how inexpensive it is relative to the company’s post-Covid trading history. 

But what about relative to other healthcare equipment players?

Excluding Inari Medical (which has an astronomical 2023 P/E ratio), the average P/E multiple on profitable mid-cap peers is 28x. This puts Integer in deep discount territory compared to its peer group. An argument can be made for a premium valuation considering the company’s expansion into development-stage services and favorable growth outlook. 

At a minimum, Integer deserves to trade in line with the group average. If its P/E ratio can expand to at least this level over time, there could be a 50% or more upside. Regardless of when Integer returns to the $100 level, ‘count’ on some nice gains ahead.

→ AI Stock Caught Trading Under Secret Name (From The Oxford Club) (Ad)

Should you invest $1,000 in Integer right now?

Before you consider Integer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.

While Integer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Integer (ITGR)
0.9137 of 5 stars
$102.00+1.8%N/A37.92Hold$99.20
Inari Medical (NARI)
1.9982 of 5 stars
$57.090.0%N/A-951.50Moderate Buy$81.29
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: